Diffusely Abnormal White Matter in Multiple Sclerosis: Further Histologic Studies Provide Evidence for a Primary Lipid Abnormality With Neurodegeneration

Abstract Although multiple sclerosis (MS) lesions have been studied extensively using histology and magnetic resonance imaging (MRI), little is known about diffusely abnormal white matter (DAWM). Diffusely abnormal white matter, regions with reduced mild MRI hyperintensity and ill-defined boundaries, show reduced myelin water fraction, and decreased Luxol fast blue staining of myelin phospholipids, with relative preservation of myelin basic protein and 2′,3′-cyclic-nucleotide 3′-phosphohydrolase. Because DAWM may be important in MS disability and progression, further histologic characterization is warranted. The MRI data were collected on 14 formalin-fixed MS brain samples that were then stained for myelin phospholipids, myelin proteins, astrocytes and axons. Diffusely abnormal white matter showed reduced myelin water fraction (−30%, p < 0.05 for 13 samples). Myelin phospholipids showed the most dramatic and consistent histologic reductions in staining optical density (−29% Luxol fast blue and −24% Weil’s, p < 0.05 for 13 and 14 samples,respectively) with lesser myelin protein involvement (−11% myelin-associated glycoprotein, −10% myelin basic protein, −8% myelin-oligodendrocyte glycoprotein, −7% proteolipid protein, −5% 2′,3′-cyclic-nucleotide 3′-phosphohydrolase, p < 0.05 for 3, 3, 1, 2, and 3 samples, respectively). Axonal involvement was intermediate. Diffusely abnormal white matter lipid and protein reductions occurred independently. These findings suggest a primary lipid abnormality in DAWM that exceeds protein loss and is accompanied by axonal degeneration. These phenomena may be important in MS pathogenesis and disease progression, which is prominent in individuals with DAWM.

[1]  G J Barker,et al.  Stereotactic co‐registration of magnetic resonance imaging and histopathology in post‐mortem multiple sclerosis brain , 2003, Neuropathology and applied neurobiology.

[2]  Christopher M. Taylor,et al.  The Transport, Assembly, and Function of Myelin Lipids , 2004 .

[3]  P. Riekkinen,et al.  Neurochemical and morphological studies on demyelination in multiple sclerosis with special reference to etiological aspects , 2004, Zeitschrift für Neurologie.

[4]  C. Ford,et al.  Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis , 1996, Neurology.

[5]  G J Barker,et al.  Disability in multiple sclerosis is related to normal appearing brain tissue MTR histogram abnormalities , 2003, Multiple sclerosis.

[6]  C. Laule,et al.  Dirty-appearing white matter in multiple sclerosis , 2008, Journal of Neurology.

[7]  B. Gerstl,et al.  Brain lipids in multiple sclerosis and other diseases. , 1961, Brain : a journal of neurology.

[8]  A. Weil A RAPID METHOD FOR STAINING MYELIN SHEATHS , 1928 .

[9]  P. Moreau Lipids , 2007 .

[10]  A. S. Hall,et al.  NUCLEAR MAGNETIC RESONANCE IMAGING OF THE BRAIN IN MULTIPLE SCLEROSIS , 1981, The Lancet.

[11]  J Versijpt,et al.  PET visualization of microglia in multiple sclerosis patients using [11C]PK11195 , 2003, European journal of neurology.

[12]  F. Barkhof,et al.  Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. , 1998, Brain : a journal of neurology.

[13]  P. Calabresi,et al.  A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis , 2008, Brain : a journal of neurology.

[14]  R Stollberger,et al.  A comparison of magnetization transfer ratio, magnetization transfer rate, and the native relaxation time of water protons related to relapsing-remitting multiple sclerosis. , 2000, AJNR. American journal of neuroradiology.

[15]  Alan C. Evans,et al.  Neuroimaging in multiple sclerosis. , 1995, Neurologic clinics.

[16]  C. Alling,et al.  Lipid alterations in apparently normal white matter in multiple sclerosis. , 1971, Brain research.

[17]  W. Brück,et al.  Interplay between mechanisms of damage and repair in multiple sclerosis , 2008, Journal of Neurology.

[18]  Douglas L. Arnold,et al.  Axonal injury in the cerebral normal-appearing white matter of patients with multiple sclerosis is related to concurrent demyelination in lesions but not to concurrent demyelination in normal-appearing white matter , 2006, NeuroImage.

[19]  I. Allen,et al.  A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis , 1979, Journal of the Neurological Sciences.

[20]  H. Woelk,et al.  Investigations of the lipid metabolism of the white matter in multiple sclerosis Changes in glycero-phosphatides and lipid-splitting enzymes , 1982, Neurochemical Research.

[21]  F. Barkhof,et al.  Cortical lesions in multiple sclerosis. , 1999, Brain : a journal of neurology.

[22]  P. Cunnea,et al.  The effects of blood-brain barrier disruption on glial cell function in multiple sclerosis. , 2009, Biochemical Society transactions.

[23]  D. Chari,et al.  Remyelination In Multiple Sclerosis , 2007, International Review of Neurobiology.

[24]  S. Reingold,et al.  The role of magnetic resonance techniques in understanding and managing multiple sclerosis. , 1998, Brain : a journal of neurology.

[25]  Nikos Evangelou,et al.  Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis , 2000, Annals of neurology.

[26]  Catrin S. Rutland Histological and Histochemical Methods 4th Edition , 2008 .

[27]  Frederik Barkhof,et al.  Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. , 2005, AJNR. American journal of neuroradiology.

[28]  R B Banati,et al.  The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. , 2000, Brain : a journal of neurology.

[29]  Y. Itoyama,et al.  Immunocytochemical observations on the distribution of myelin‐associated glycoprotein and myelin basic protein in multiple sclerosis lesions , 1980, Annals of neurology.

[30]  J. Cumings Lipid chemistry of the brain in demyelinating diseases. , 1955, Brain : a journal of neurology.

[31]  W. Mcdonald,et al.  The pathological evolution of multiple sclerosis , 1992, Neuropathology and applied neurobiology.

[32]  T. N. Salthouse,et al.  Luxol fast blue ARN: a new solvent azo dye with improved staining qualities for myelin and phospholipids. , 1962, Stain technology.

[33]  P. Adamson,et al.  Reactive oxygen species enhance the migration of monocytes across the blood‐brain barrier in vitro , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  D D Breimer,et al.  The blood-brain barrier in neuroinflammatory diseases. , 1997, Pharmacological reviews.

[35]  B. Trapp,et al.  Structure of the Myelinated Axon , 2004 .

[36]  N. Gourtsoyiannis,et al.  T2 relaxation time analysis in patients with multiple sclerosis: correlation with magnetization transfer ratio , 2004, European Radiology.

[37]  C. W. Adams,et al.  HISTOCHEMISTRY OF MYELIN. XIII DIGESTION OF BASIC PROTEIN OUTSIDE ACUTE PLAQUES OF MULTIPLE SCLEROSIS , 1971 .

[38]  Abnormal endothelial tight junctions in active lesions and normal-appearing white matter in multiple sclerosis. , 2002, Brain pathology.

[39]  V. Perry,et al.  Axonal damage in acute multiple sclerosis lesions. , 1997, Brain : a journal of neurology.

[40]  F. Barkhof,et al.  Diffusely Abnormal White Matter in Progressive Multiple Sclerosis: In Vivo Quantitative MR Imaging Characterization and Comparison between Disease Types , 2010, American Journal of Neuroradiology.

[41]  P. Sørensen,et al.  Demyelination versus remyelination in progressive multiple sclerosis. , 2010, Brain : a journal of neurology.

[42]  J. Clausen,et al.  MYELIN CONSTITUENTS OF HUMAN CENTRAL NERVOUS SYSTEM , 1970, Acta neurologica Scandinavica.

[43]  Jimmy Lee,et al.  Reproducibility of myelin water fraction analysis: a comparison of region of interest and voxel-based analysis methods. , 2009, Magnetic resonance imaging.

[44]  L. Eng,et al.  LIPIDS AND PROTEINS IN MULTIPLE SCLEROSIS WHITE MATTER 1 , 1970, Journal of neurochemistry.

[45]  P. Scheltens,et al.  MR of the spinal cord in multiple sclerosis: relation to clinical subtype and disability. , 1997, AJNR. American journal of neuroradiology.

[46]  R. Shi,et al.  Acrolein induces myelin damage in mammalian spinal cord , 2011, Journal of neurochemistry.

[47]  F Barkhof,et al.  Normal-appearing white matter changes vary with distance to lesions in multiple sclerosis. , 2006, AJNR. American journal of neuroradiology.

[48]  Kenneth J. Smith,et al.  Demyelination: The Role of Reactive Oxygen and Nitrogen Species , 1999, Brain pathology.

[49]  J. Cossins,et al.  Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions , 1997, Acta Neuropathologica.

[50]  Alex L. MacKay,et al.  Quantitative interpretation of NMR relaxation data , 1989 .

[51]  Piotr Kozlowski,et al.  Myelin water imaging of multiple sclerosis at 7 T: Correlations with histopathology , 2008, NeuroImage.

[52]  A. J. Thompson,et al.  Magnetic resonance studies of abnormalities in the normal appearing white matter and grey matter in multiple sclerosis , 2003, Journal of Neurology.

[53]  J. Newcombe,et al.  White Matter Proteins in Multiple Sclerosis , 1980, Journal of neurochemistry.

[54]  Frederik Barkhof,et al.  Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis. , 2009, Archives of neurology.

[55]  C. Laule,et al.  Two-year study of cervical cord volume and myelin water in primary progressive multiple sclerosis , 2010, Multiple sclerosis.

[56]  S. Nelson,et al.  Multislice Brain Myelin Water Fractions at 3T in Multiple Sclerosis , 2007, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[57]  K. Suzuki,et al.  Myelin in multiple sclerosis. Composition of myelin from normal-appearing white matter. , 1973, Archives of neurology.

[58]  R. Rudick,et al.  Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.

[59]  A J Thompson,et al.  A comparison of the pathology of primary and secondary progressive multiple sclerosis. , 1994, Brain : a journal of neurology.

[60]  A. Thompson,et al.  Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis. , 2004, Brain : a journal of neurology.

[61]  P. Matthews,et al.  Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. , 2000, Brain : a journal of neurology.

[62]  I. V. Allen,et al.  Pathological abnormalities in the normal-appearing white matter in multiple sclerosis , 2001, Neurological Sciences.

[63]  F. Barkhof,et al.  Diffuse signal abnormalities in the spinal cord in multiple sclerosis: Direct postmortem in situ magnetic resonance imaging correlated with in vitro high‐resolution magnetic resonance imaging and histopathology , 2002, Annals of neurology.

[64]  C. Laule,et al.  Myelin water imaging in multiple sclerosis: quantitative correlations with histopathology , 2006, Multiple sclerosis.

[65]  H. Klüver,et al.  A method for the combined staining of cells and fibers in the nervous system. , 1953, Journal of neuropathology and experimental neurology.

[66]  S Ropele,et al.  Magnetization transfer ratio measurement in multiple sclerosis normal-appearing brain tissue: limited differences with controls but relationships with clinical and MR measures of disease , 2007, Multiple sclerosis.

[67]  F. Barkhof,et al.  Blood–brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis , 2005, Neurobiology of Disease.

[68]  G. Comi,et al.  MRI quantification of gray and white matter damage in patients with early–onset multiple sclerosis , 2006, Journal of Neurology.

[69]  Frederik Barkhof,et al.  Multislice T1 relaxation time measurements in the brain using IR‐EPI: Reproducibility, normal values, and histogram analysis in patients with multiple sclerosis , 2003, Journal of magnetic resonance imaging : JMRI.

[70]  Piotr Kozlowski,et al.  Pathological basis of diffusely abnormal white matter: insights from magnetic resonance imaging and histology , 2011, Multiple sclerosis.

[71]  R M Lycette,et al.  The binding of luxol fast blue ARN by various biological lipids. , 1970, Stain technology.

[72]  Christine Stadelmann,et al.  Wallerian Degeneration: A Major Component of Early Axonal Pathology in Multiple Sclerosis , 2010, Brain pathology.

[73]  J. Newcombe,et al.  Increased blood vessel density and endothelial cell proliferation in multiple sclerosis cerebral white matter , 2010, Neuroscience Letters.

[74]  I. Allen,et al.  Abnormalities in the macroscopically normal white matter in cases of mild or spinal multiple sclerosis (MS). , 1981, Acta neuropathologica. Supplementum.

[75]  Craig K. Jones,et al.  Normal‐appearing white matter in multiple sclerosis has heterogeneous, diffusely prolonged T2 , 2002, Magnetic resonance in medicine.

[76]  P. Garland Lipid Chemistry , 2020, Nature.

[77]  J. Whitaker The distribution of myelin basic protein in central nervous system lesions of multiple sclerosis and acute experimental allergic encephalomyelitis , 1978, Annals of neurology.

[78]  J. Babb,et al.  Dirty-appearing white matter in multiple sclerosis: volumetric MR imaging and magnetization transfer ratio histogram analysis. , 2003, AJNR. American journal of neuroradiology.

[79]  H. Lassmann,et al.  Chapter 1 – The story of multiple sclerosis , 2006 .

[80]  P. Riekkinen,et al.  Studies on the Pathogenesis of Multiple Sclerosis , 1971 .

[81]  K. Misulis,et al.  DEMYELINATING diseases. , 1952, Lancet.

[82]  J A Frank,et al.  MRI T2 lesion burden in multiple sclerosis , 2006, Neurology.

[83]  R. Brady,et al.  Quantitation of the Myelin‐Associated Glycoprotein in Human Nervous Tissue from Controls and Multiple Sclerosis Patients , 1986, Journal of neurochemistry.

[84]  J. Geurts,et al.  Gray matter imaging in multiple sclerosis: what have we learned? , 2011, BMC neurology.

[85]  G Macchi,et al.  An in vivo and post mortem MRI study in multiple sclerosis with pathological correlation. , 1992, Italian journal of neurological sciences.

[86]  Massimo Filippi,et al.  The role of advanced magnetic resonance imaging techniques in primary progressive MS , 2012, Journal of Neurology.

[87]  H. Debuch,et al.  2′, 3′‐Cyclic Nucleotide 3′‐Phosphohydrolase and Lipids of Myelin from Multiple Sclerosis and Normal Brains , 1980, Journal of neurochemistry.

[88]  L. Laitinen,et al.  Studies on the pathogenesis of multiple sclerosis. Participation of lysosomes on demyelination in the central nervous system white matter outside plaques. , 1973, European neurology.

[89]  T. Inoue,et al.  Formalin fixed brains are useful for magnetic resonance imaging (MRI) study , 1987, Journal of the Neurological Sciences.

[90]  M. Filippi,et al.  Intrinsic damage to the major white matter tracts in patients with different clinical phenotypes of multiple sclerosis: a voxelwise diffusion-tensor MR study. , 2011, Radiology.

[91]  Helga E. de Vries,et al.  Matrix metalloproteinase-12 is expressed in phagocytotic macrophages in active multiple sclerosis lesions , 2003, Journal of Neuroimmunology.

[92]  J. Bancroft,et al.  Theory and Practice of Histological Techniques , 1990 .

[93]  F. Barkhof,et al.  Spinal cord magnetic resonance imaging in suspected multiple sclerosis , 2000, European Radiology.